Inspira Technologies Oxy B.H.N. Ltd. (IINN) Stock Competitors & Peer Comparison
See (IINN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IINN | $2.01 | +5.79% | 48.4M | -4.47 | -$0.45 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $90.49 | -0.04% | 157.7B | 17.37 | $5.21 | +2.67% |
| ISRG | $401.83 | -0.33% | 142.3B | 41.78 | $9.62 | N/A |
| SYK | $313.68 | +1.19% | 120.3B | 23.43 | $13.39 | +1.09% |
| MDT | $80.13 | -0.62% | 102.9B | 14.49 | $5.53 | +3.52% |
| BSX | $44.46 | -2.50% | 66.1B | 14.34 | $3.10 | N/A |
| EW | $89.66 | +3.12% | 51.6B | 48.46 | $1.85 | N/A |
| RMD | $196.50 | +2.74% | 28.5B | 18.24 | $10.77 | +1.23% |
| DXCM | $69.75 | +1.20% | 26.9B | 29.93 | $2.33 | N/A |
Stock Comparison
IINN vs BSX-PA Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, IINN is priced at $2.01, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, IINN's ROE is -2.78%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, IINN is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BSX-PA's competition here
IINN vs ABT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ABT has a market cap of 157.7B. Regarding current trading prices, IINN is priced at $2.01, while ABT trades at $90.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ABT's P/E ratio is 17.37. In terms of profitability, IINN's ROE is -2.78%, compared to ABT's ROE of +0.12%. Regarding short-term risk, IINN is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ABT's competition here
IINN vs ISRG Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ISRG has a market cap of 142.3B. Regarding current trading prices, IINN is priced at $2.01, while ISRG trades at $401.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ISRG's P/E ratio is 41.78. In terms of profitability, IINN's ROE is -2.78%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, IINN is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ISRG's competition here
IINN vs SYK Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SYK has a market cap of 120.3B. Regarding current trading prices, IINN is priced at $2.01, while SYK trades at $313.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SYK's P/E ratio is 23.43. In terms of profitability, IINN's ROE is -2.78%, compared to SYK's ROE of +0.15%. Regarding short-term risk, IINN is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SYK's competition here
IINN vs MDT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, MDT has a market cap of 102.9B. Regarding current trading prices, IINN is priced at $2.01, while MDT trades at $80.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas MDT's P/E ratio is 14.49. In terms of profitability, IINN's ROE is -2.78%, compared to MDT's ROE of +0.10%. Regarding short-term risk, IINN is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check MDT's competition here
IINN vs BSX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BSX has a market cap of 66.1B. Regarding current trading prices, IINN is priced at $2.01, while BSX trades at $44.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BSX's P/E ratio is 14.34. In terms of profitability, IINN's ROE is -2.78%, compared to BSX's ROE of +0.15%. Regarding short-term risk, IINN is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BSX's competition here
IINN vs EW Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, EW has a market cap of 51.6B. Regarding current trading prices, IINN is priced at $2.01, while EW trades at $89.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas EW's P/E ratio is 48.46. In terms of profitability, IINN's ROE is -2.78%, compared to EW's ROE of +0.11%. Regarding short-term risk, IINN is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check EW's competition here
IINN vs RMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, RMD has a market cap of 28.5B. Regarding current trading prices, IINN is priced at $2.01, while RMD trades at $196.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas RMD's P/E ratio is 18.24. In terms of profitability, IINN's ROE is -2.78%, compared to RMD's ROE of +0.24%. Regarding short-term risk, IINN is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check RMD's competition here
IINN vs DXCM Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, DXCM has a market cap of 26.9B. Regarding current trading prices, IINN is priced at $2.01, while DXCM trades at $69.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas DXCM's P/E ratio is 29.93. In terms of profitability, IINN's ROE is -2.78%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, IINN is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check DXCM's competition here
IINN vs PHG Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PHG has a market cap of 26B. Regarding current trading prices, IINN is priced at $2.01, while PHG trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PHG's P/E ratio is 23.24. In terms of profitability, IINN's ROE is -2.78%, compared to PHG's ROE of +0.09%. Regarding short-term risk, IINN is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PHG's competition here
IINN vs STE Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, STE has a market cap of 20.2B. Regarding current trading prices, IINN is priced at $2.01, while STE trades at $207.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas STE's P/E ratio is 26.08. In terms of profitability, IINN's ROE is -2.78%, compared to STE's ROE of +0.11%. Regarding short-term risk, IINN is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check STE's competition here
IINN vs ZBH Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ZBH has a market cap of 17.5B. Regarding current trading prices, IINN is priced at $2.01, while ZBH trades at $90.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ZBH's P/E ratio is 23.46. In terms of profitability, IINN's ROE is -2.78%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, IINN is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ZBH's competition here
IINN vs ABMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, IINN is priced at $2.01, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ABMD's P/E ratio is 65.36. In terms of profitability, IINN's ROE is -2.78%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, IINN is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ABMD's competition here
IINN vs SNN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SNN has a market cap of 12.8B. Regarding current trading prices, IINN is priced at $2.01, while SNN trades at $30.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SNN's P/E ratio is 21.15. In terms of profitability, IINN's ROE is -2.78%, compared to SNN's ROE of +0.12%. Regarding short-term risk, IINN is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SNN's competition here
IINN vs SWAV Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, IINN is priced at $2.01, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SWAV's P/E ratio is 78.76. In terms of profitability, IINN's ROE is -2.78%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, IINN is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SWAV's competition here
IINN vs PEN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PEN has a market cap of 12.4B. Regarding current trading prices, IINN is priced at $2.01, while PEN trades at $316.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PEN's P/E ratio is 73.08. In terms of profitability, IINN's ROE is -2.78%, compared to PEN's ROE of +0.12%. Regarding short-term risk, IINN is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PEN's competition here
IINN vs ALGN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ALGN has a market cap of 12.2B. Regarding current trading prices, IINN is priced at $2.01, while ALGN trades at $170.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ALGN's P/E ratio is 15.58. In terms of profitability, IINN's ROE is -2.78%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, IINN is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ALGN's competition here
IINN vs GMED Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, IINN is priced at $2.01, while GMED trades at $82.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas GMED's P/E ratio is 18.50. In terms of profitability, IINN's ROE is -2.78%, compared to GMED's ROE of +0.13%. Regarding short-term risk, IINN is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check GMED's competition here
IINN vs PODD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PODD has a market cap of 10.3B. Regarding current trading prices, IINN is priced at $2.01, while PODD trades at $148.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PODD's P/E ratio is 34.79. In terms of profitability, IINN's ROE is -2.78%, compared to PODD's ROE of +0.21%. Regarding short-term risk, IINN is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PODD's competition here
IINN vs MASI Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, IINN is priced at $2.01, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas MASI's P/E ratio is 44.43. In terms of profitability, IINN's ROE is -2.78%, compared to MASI's ROE of +0.09%. Regarding short-term risk, IINN is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check MASI's competition here
IINN vs BRKR Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BRKR has a market cap of 8.9B. Regarding current trading prices, IINN is priced at $2.01, while BRKR trades at $58.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BRKR's P/E ratio is 32.11. In terms of profitability, IINN's ROE is -2.78%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, IINN is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BRKR's competition here
IINN vs BRKRP Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, IINN is priced at $2.01, while BRKRP trades at $429.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BRKRP's P/E ratio is N/A. In terms of profitability, IINN's ROE is -2.78%, compared to BRKRP's ROE of -0.01%. Regarding short-term risk, IINN is more volatile compared to BRKRP. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BRKRP's competition here
IINN vs GKOS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, GKOS has a market cap of 8.1B. Regarding current trading prices, IINN is priced at $2.01, while GKOS trades at $137.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas GKOS's P/E ratio is -160.18. In terms of profitability, IINN's ROE is -2.78%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, IINN is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check GKOS's competition here
IINN vs BIO Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BIO has a market cap of 7.6B. Regarding current trading prices, IINN is priced at $2.01, while BIO trades at $280.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BIO's P/E ratio is 30.20. In terms of profitability, IINN's ROE is -2.78%, compared to BIO's ROE of +0.02%. Regarding short-term risk, IINN is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BIO's competition here
IINN vs BIO-B Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BIO-B has a market cap of 7.5B. Regarding current trading prices, IINN is priced at $2.01, while BIO-B trades at $296.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BIO-B's P/E ratio is 87.96. In terms of profitability, IINN's ROE is -2.78%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, IINN is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BIO-B's competition here
IINN vs NARI Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, IINN is priced at $2.01, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas NARI's P/E ratio is -59.24. In terms of profitability, IINN's ROE is -2.78%, compared to NARI's ROE of -0.00%. Regarding short-term risk, IINN is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check NARI's competition here
IINN vs LIVN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, IINN is priced at $2.01, while LIVN trades at $79.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas LIVN's P/E ratio is 40.79. In terms of profitability, IINN's ROE is -2.78%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, IINN is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check LIVN's competition here
IINN vs IRTC Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, IINN is priced at $2.01, while IRTC trades at $112.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas IRTC's P/E ratio is -200.84. In terms of profitability, IINN's ROE is -2.78%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, IINN is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check IRTC's competition here
IINN vs AXNX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, IINN is priced at $2.01, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas AXNX's P/E ratio is -709.80. In terms of profitability, IINN's ROE is -2.78%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, IINN is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check AXNX's competition here
IINN vs ITGR Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ITGR has a market cap of 3.1B. Regarding current trading prices, IINN is priced at $2.01, while ITGR trades at $91.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ITGR's P/E ratio is 14.51. In terms of profitability, IINN's ROE is -2.78%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, IINN is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ITGR's competition here
IINN vs TMDX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, TMDX has a market cap of 2.7B. Regarding current trading prices, IINN is priced at $2.01, while TMDX trades at $77.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas TMDX's P/E ratio is 17.76. In terms of profitability, IINN's ROE is -2.78%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, IINN is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check TMDX's competition here
IINN vs ESTA Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ESTA has a market cap of 2.6B. Regarding current trading prices, IINN is priced at $2.01, while ESTA trades at $87.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ESTA's P/E ratio is -60.56. In terms of profitability, IINN's ROE is -2.78%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, IINN is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ESTA's competition here
IINN vs AXGN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, IINN is priced at $2.01, while AXGN trades at $42.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas AXGN's P/E ratio is 111.89. In terms of profitability, IINN's ROE is -2.78%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, IINN is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check AXGN's competition here
IINN vs NUVA Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, IINN is priced at $2.01, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas NUVA's P/E ratio is 75.00. In terms of profitability, IINN's ROE is -2.78%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, IINN is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check NUVA's competition here
IINN vs BFLY Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BFLY has a market cap of 2B. Regarding current trading prices, IINN is priced at $2.01, while BFLY trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BFLY's P/E ratio is -32.40. In terms of profitability, IINN's ROE is -2.78%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, IINN is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BFLY's competition here
IINN vs UFPT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, IINN is priced at $2.01, while UFPT trades at $242.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas UFPT's P/E ratio is 24.77. In terms of profitability, IINN's ROE is -2.78%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, IINN is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check UFPT's competition here
IINN vs IART Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, IINN is priced at $2.01, while IART trades at $17.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas IART's P/E ratio is -2.75. In terms of profitability, IINN's ROE is -2.78%, compared to IART's ROE of -0.48%. Regarding short-term risk, IINN is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check IART's competition here
IINN vs AHCO Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, AHCO has a market cap of 1.4B. Regarding current trading prices, IINN is priced at $2.01, while AHCO trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas AHCO's P/E ratio is -17.00. In terms of profitability, IINN's ROE is -2.78%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, IINN is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check AHCO's competition here
IINN vs ATEC Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ATEC has a market cap of 1.3B. Regarding current trading prices, IINN is priced at $2.01, while ATEC trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ATEC's P/E ratio is -10.48. In terms of profitability, IINN's ROE is -2.78%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, IINN is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ATEC's competition here
IINN vs HSKA Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, IINN is priced at $2.01, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas HSKA's P/E ratio is -62.49. In terms of profitability, IINN's ROE is -2.78%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, IINN is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check HSKA's competition here
IINN vs INSP Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, INSP has a market cap of 1.2B. Regarding current trading prices, IINN is priced at $2.01, while INSP trades at $43.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas INSP's P/E ratio is 16.76. In terms of profitability, IINN's ROE is -2.78%, compared to INSP's ROE of +0.18%. Regarding short-term risk, IINN is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check INSP's competition here
IINN vs ENOV Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ENOV has a market cap of 1.2B. Regarding current trading prices, IINN is priced at $2.01, while ENOV trades at $21.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ENOV's P/E ratio is 6.33. In terms of profitability, IINN's ROE is -2.78%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, IINN is more volatile compared to ENOV. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ENOV's competition here
IINN vs IRMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, IINN is priced at $2.01, while IRMD trades at $94.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas IRMD's P/E ratio is 47.59. In terms of profitability, IINN's ROE is -2.78%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, IINN is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check IRMD's competition here
IINN vs PRCT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, IINN is priced at $2.01, while PRCT trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PRCT's P/E ratio is -11.46. In terms of profitability, IINN's ROE is -2.78%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, IINN is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PRCT's competition here
IINN vs AVNS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, IINN is priced at $2.01, while AVNS trades at $24.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas AVNS's P/E ratio is 27.66. In terms of profitability, IINN's ROE is -2.78%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, IINN is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check AVNS's competition here
IINN vs SILK Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, IINN is priced at $2.01, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SILK's P/E ratio is -18.96. In terms of profitability, IINN's ROE is -2.78%, compared to SILK's ROE of -0.35%. Regarding short-term risk, IINN is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SILK's competition here
IINN vs FNA Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, IINN is priced at $2.01, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas FNA's P/E ratio is -19.83. In terms of profitability, IINN's ROE is -2.78%, compared to FNA's ROE of -0.35%. Regarding short-term risk, IINN is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check FNA's competition here
IINN vs AORT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, IINN is priced at $2.01, while AORT trades at $22.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas AORT's P/E ratio is 33.91. In terms of profitability, IINN's ROE is -2.78%, compared to AORT's ROE of +0.03%. Regarding short-term risk, IINN is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check AORT's competition here
IINN vs CNMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CNMD has a market cap of 1.1B. Regarding current trading prices, IINN is priced at $2.01, while CNMD trades at $35.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CNMD's P/E ratio is 7.77. In terms of profitability, IINN's ROE is -2.78%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, IINN is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CNMD's competition here
IINN vs TNDM Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, TNDM has a market cap of 1B. Regarding current trading prices, IINN is priced at $2.01, while TNDM trades at $15.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas TNDM's P/E ratio is -13.65. In terms of profitability, IINN's ROE is -2.78%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, IINN is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check TNDM's competition here
IINN vs LMRI Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, LMRI has a market cap of 958.9M. Regarding current trading prices, IINN is priced at $2.01, while LMRI trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas LMRI's P/E ratio is -19.42. In terms of profitability, IINN's ROE is -2.78%, compared to LMRI's ROE of -0.14%. Regarding short-term risk, IINN is more volatile compared to LMRI. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check LMRI's competition here
IINN vs INMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, INMD has a market cap of 937.1M. Regarding current trading prices, IINN is priced at $2.01, while INMD trades at $14.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas INMD's P/E ratio is 9.48. In terms of profitability, IINN's ROE is -2.78%, compared to INMD's ROE of +0.13%. Regarding short-term risk, IINN is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check INMD's competition here
IINN vs CSII Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, IINN is priced at $2.01, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CSII's P/E ratio is -20.83. In terms of profitability, IINN's ROE is -2.78%, compared to CSII's ROE of -0.14%. Regarding short-term risk, IINN is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CSII's competition here
IINN vs CRY Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, IINN is priced at $2.01, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CRY's P/E ratio is 425.71. In terms of profitability, IINN's ROE is -2.78%, compared to CRY's ROE of +0.03%. Regarding short-term risk, IINN is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CRY's competition here
IINN vs SIBN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SIBN has a market cap of 724.7M. Regarding current trading prices, IINN is priced at $2.01, while SIBN trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SIBN's P/E ratio is -41.90. In terms of profitability, IINN's ROE is -2.78%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, IINN is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SIBN's competition here
IINN vs SSII Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SSII has a market cap of 714.5M. Regarding current trading prices, IINN is priced at $2.01, while SSII trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SSII's P/E ratio is -69.63. In terms of profitability, IINN's ROE is -2.78%, compared to SSII's ROE of -0.23%. Regarding short-term risk, IINN is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SSII's competition here
IINN vs CBLL Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CBLL has a market cap of 706.1M. Regarding current trading prices, IINN is priced at $2.01, while CBLL trades at $18.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CBLL's P/E ratio is -11.42. In terms of profitability, IINN's ROE is -2.78%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, IINN is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CBLL's competition here
IINN vs BVS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BVS has a market cap of 643.6M. Regarding current trading prices, IINN is priced at $2.01, while BVS trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BVS's P/E ratio is 23.17. In terms of profitability, IINN's ROE is -2.78%, compared to BVS's ROE of +0.16%. Regarding short-term risk, IINN is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BVS's competition here
IINN vs TCMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, TCMD has a market cap of 620.1M. Regarding current trading prices, IINN is priced at $2.01, while TCMD trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas TCMD's P/E ratio is 31.24. In terms of profitability, IINN's ROE is -2.78%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, IINN is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check TCMD's competition here
IINN vs SRDX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, IINN is priced at $2.01, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SRDX's P/E ratio is -34.66. In terms of profitability, IINN's ROE is -2.78%, compared to SRDX's ROE of -0.13%. Regarding short-term risk, IINN is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SRDX's competition here
IINN vs APEN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, IINN is priced at $2.01, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas APEN's P/E ratio is -9.43. In terms of profitability, IINN's ROE is -2.78%, compared to APEN's ROE of -0.85%. Regarding short-term risk, IINN is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check APEN's competition here
IINN vs BWAY Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BWAY has a market cap of 564.8M. Regarding current trading prices, IINN is priced at $2.01, while BWAY trades at $14.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BWAY's P/E ratio is 36.58. In terms of profitability, IINN's ROE is -2.78%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, IINN is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check BWAY's competition here
IINN vs NPCE Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, NPCE has a market cap of 553M. Regarding current trading prices, IINN is priced at $2.01, while NPCE trades at $16.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas NPCE's P/E ratio is -24.95. In terms of profitability, IINN's ROE is -2.78%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, IINN is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check NPCE's competition here
IINN vs CTKB Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CTKB has a market cap of 551.4M. Regarding current trading prices, IINN is priced at $2.01, while CTKB trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CTKB's P/E ratio is -32.85. In terms of profitability, IINN's ROE is -2.78%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, IINN is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CTKB's competition here
IINN vs CLPT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CLPT has a market cap of 539.2M. Regarding current trading prices, IINN is priced at $2.01, while CLPT trades at $17.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CLPT's P/E ratio is -17.80. In terms of profitability, IINN's ROE is -2.78%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, IINN is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CLPT's competition here
IINN vs ZIMV Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, IINN is priced at $2.01, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, IINN's ROE is -2.78%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, IINN is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ZIMV's competition here
IINN vs CERS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CERS has a market cap of 529M. Regarding current trading prices, IINN is priced at $2.01, while CERS trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CERS's P/E ratio is -52.69. In terms of profitability, IINN's ROE is -2.78%, compared to CERS's ROE of -0.15%. Regarding short-term risk, IINN is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CERS's competition here
IINN vs KIDS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, KIDS has a market cap of 492.1M. Regarding current trading prices, IINN is priced at $2.01, while KIDS trades at $19.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas KIDS's P/E ratio is -18.60. In terms of profitability, IINN's ROE is -2.78%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, IINN is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check KIDS's competition here
IINN vs PACB Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PACB has a market cap of 447.3M. Regarding current trading prices, IINN is priced at $2.01, while PACB trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PACB's P/E ratio is -2.94. In terms of profitability, IINN's ROE is -2.78%, compared to PACB's ROE of -4.88%. Regarding short-term risk, IINN is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PACB's competition here
IINN vs VMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, VMD has a market cap of 439.7M. Regarding current trading prices, IINN is priced at $2.01, while VMD trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas VMD's P/E ratio is 31.00. In terms of profitability, IINN's ROE is -2.78%, compared to VMD's ROE of +0.11%. Regarding short-term risk, IINN is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check VMD's competition here
IINN vs VREX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, VREX has a market cap of 436.6M. Regarding current trading prices, IINN is priced at $2.01, while VREX trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas VREX's P/E ratio is 10.92. In terms of profitability, IINN's ROE is -2.78%, compared to VREX's ROE of -0.18%. Regarding short-term risk, IINN is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check VREX's competition here
IINN vs DCTH Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, DCTH has a market cap of 422.5M. Regarding current trading prices, IINN is priced at $2.01, while DCTH trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas DCTH's P/E ratio is 1224.00. In terms of profitability, IINN's ROE is -2.78%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, IINN is more volatile compared to DCTH. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check DCTH's competition here
IINN vs AVR Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, AVR has a market cap of 382.6M. Regarding current trading prices, IINN is priced at $2.01, while AVR trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas AVR's P/E ratio is -4.66. In terms of profitability, IINN's ROE is -2.78%, compared to AVR's ROE of -1.24%. Regarding short-term risk, IINN is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check AVR's competition here
IINN vs OFIX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, OFIX has a market cap of 378.3M. Regarding current trading prices, IINN is priced at $2.01, while OFIX trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas OFIX's P/E ratio is -6.24. In terms of profitability, IINN's ROE is -2.78%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, IINN is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check OFIX's competition here
IINN vs MASS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, MASS has a market cap of 339.2M. Regarding current trading prices, IINN is priced at $2.01, while MASS trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas MASS's P/E ratio is -9.25. In terms of profitability, IINN's ROE is -2.78%, compared to MASS's ROE of -0.26%. Regarding short-term risk, IINN is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check MASS's competition here
IINN vs ELMD Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ELMD has a market cap of 322.8M. Regarding current trading prices, IINN is priced at $2.01, while ELMD trades at $39.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ELMD's P/E ratio is 33.32. In terms of profitability, IINN's ROE is -2.78%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, IINN is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ELMD's competition here
IINN vs SMLR Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, IINN is priced at $2.01, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SMLR's P/E ratio is 3.92. In terms of profitability, IINN's ROE is -2.78%, compared to SMLR's ROE of +0.16%. Regarding short-term risk, IINN is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SMLR's competition here
IINN vs SGHT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SGHT has a market cap of 299.3M. Regarding current trading prices, IINN is priced at $2.01, while SGHT trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SGHT's P/E ratio is -8.73. In terms of profitability, IINN's ROE is -2.78%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, IINN is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SGHT's competition here
IINN vs LAB Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, LAB has a market cap of 293.9M. Regarding current trading prices, IINN is priced at $2.01, while LAB trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas LAB's P/E ratio is -5.79. In terms of profitability, IINN's ROE is -2.78%, compared to LAB's ROE of -0.21%. Regarding short-term risk, IINN is more volatile compared to LAB. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check LAB's competition here
IINN vs TMCI Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, TMCI has a market cap of 267.9M. Regarding current trading prices, IINN is priced at $2.01, while TMCI trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas TMCI's P/E ratio is -4.30. In terms of profitability, IINN's ROE is -2.78%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, IINN is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check TMCI's competition here
IINN vs PMI Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PMI has a market cap of 267.7M. Regarding current trading prices, IINN is priced at $2.01, while PMI trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PMI's P/E ratio is -0.14. In terms of profitability, IINN's ROE is -2.78%, compared to PMI's ROE of +4.99%. Regarding short-term risk, IINN is more volatile compared to PMI. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PMI's competition here
IINN vs MGRM Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, IINN is priced at $2.01, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas MGRM's P/E ratio is -11.11. In terms of profitability, IINN's ROE is -2.78%, compared to MGRM's ROE of -1.11%. Regarding short-term risk, IINN is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check MGRM's competition here
IINN vs SENS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, SENS has a market cap of 237.6M. Regarding current trading prices, IINN is priced at $2.01, while SENS trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas SENS's P/E ratio is -2.84. In terms of profitability, IINN's ROE is -2.78%, compared to SENS's ROE of -1.30%. Regarding short-term risk, IINN is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check SENS's competition here
IINN vs CATX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CATX has a market cap of 231M. Regarding current trading prices, IINN is priced at $2.01, while CATX trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CATX's P/E ratio is -2.12. In terms of profitability, IINN's ROE is -2.78%, compared to CATX's ROE of -0.42%. Regarding short-term risk, IINN is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CATX's competition here
IINN vs NVRO Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, IINN is priced at $2.01, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas NVRO's P/E ratio is -1.91. In terms of profitability, IINN's ROE is -2.78%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, IINN is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check NVRO's competition here
IINN vs RXST Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, RXST has a market cap of 219.8M. Regarding current trading prices, IINN is priced at $2.01, while RXST trades at $5.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas RXST's P/E ratio is -7.37. In terms of profitability, IINN's ROE is -2.78%, compared to RXST's ROE of -0.17%. Regarding short-term risk, IINN is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check RXST's competition here
IINN vs EYES Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, IINN is priced at $2.01, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas EYES's P/E ratio is N/A. In terms of profitability, IINN's ROE is -2.78%, compared to EYES's ROE of -2.64%. Regarding short-term risk, IINN is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check EYES's competition here
IINN vs PROF Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, PROF has a market cap of 197M. Regarding current trading prices, IINN is priced at $2.01, while PROF trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas PROF's P/E ratio is -5.25. In terms of profitability, IINN's ROE is -2.78%, compared to PROF's ROE of -0.70%. Regarding short-term risk, IINN is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check PROF's competition here
IINN vs ANIK Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, ANIK has a market cap of 196M. Regarding current trading prices, IINN is priced at $2.01, while ANIK trades at $14.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas ANIK's P/E ratio is 30.06. In terms of profitability, IINN's ROE is -2.78%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, IINN is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check ANIK's competition here
IINN vs BSGM Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, IINN is priced at $2.01, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas BSGM's P/E ratio is -5.81. In terms of profitability, IINN's ROE is -2.78%, compared to BSGM's ROE of +17.60%. Regarding short-term risk, IINN is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for IINN.Check BSGM's competition here
IINN vs FOCL Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, FOCL has a market cap of 190.2M. Regarding current trading prices, IINN is priced at $2.01, while FOCL trades at $5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas FOCL's P/E ratio is -10.26. In terms of profitability, IINN's ROE is -2.78%, compared to FOCL's ROE of -1.37%. Regarding short-term risk, IINN is more volatile compared to FOCL. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check FOCL's competition here
IINN vs INGN Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, INGN has a market cap of 183M. Regarding current trading prices, IINN is priced at $2.01, while INGN trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas INGN's P/E ratio is -7.43. In terms of profitability, IINN's ROE is -2.78%, compared to INGN's ROE of -0.13%. Regarding short-term risk, IINN is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check INGN's competition here
IINN vs MDGS Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, IINN is priced at $2.01, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas MDGS's P/E ratio is -0.27. In terms of profitability, IINN's ROE is -2.78%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, IINN is more volatile compared to MDGS. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check MDGS's competition here
IINN vs EDAP Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, IINN is priced at $2.01, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas EDAP's P/E ratio is -5.80. In terms of profitability, IINN's ROE is -2.78%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, IINN is more volatile compared to EDAP. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check EDAP's competition here
IINN vs QTRX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, QTRX has a market cap of 178.1M. Regarding current trading prices, IINN is priced at $2.01, while QTRX trades at $3.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas QTRX's P/E ratio is -2.36. In terms of profitability, IINN's ROE is -2.78%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, IINN is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check QTRX's competition here
IINN vs APYX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, APYX has a market cap of 172.5M. Regarding current trading prices, IINN is priced at $2.01, while APYX trades at $4.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas APYX's P/E ratio is -18.73. In terms of profitability, IINN's ROE is -2.78%, compared to APYX's ROE of -0.91%. Regarding short-term risk, IINN is more volatile compared to APYX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check APYX's competition here
IINN vs QIPT Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, IINN is priced at $2.01, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas QIPT's P/E ratio is -15.87. In terms of profitability, IINN's ROE is -2.78%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, IINN is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check QIPT's competition here
IINN vs TLSI Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, TLSI has a market cap of 157.7M. Regarding current trading prices, IINN is priced at $2.01, while TLSI trades at $4.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas TLSI's P/E ratio is -2.48. In terms of profitability, IINN's ROE is -2.78%, compared to TLSI's ROE of +1.63%. Regarding short-term risk, IINN is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check TLSI's competition here
IINN vs CVRX Comparison June 2026
IINN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IINN stands at 48.4M. In comparison, CVRX has a market cap of 136.8M. Regarding current trading prices, IINN is priced at $2.01, while CVRX trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IINN currently has a P/E ratio of -4.47, whereas CVRX's P/E ratio is -2.55. In terms of profitability, IINN's ROE is -2.78%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, IINN is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for IINN.Check CVRX's competition here